TP53 Mutation Subtypes and Outcomes with First-Line EGFR-TKI Monotherapy in EGFR-mutant Non-Small Cell Lung Cancer: A Nationwide C-CAT Analysis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Lung Cancer Treatments and Mutations
Lung Cancer Diagnosis and Treatment
Cancer Genomics and Diagnostics
Publication details
- Journal / source
- SSRN Electronic Journal
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint